Osartil Plus 100 mg+25 mg (Tablet)

Indications

• Treatment of hypertension
• Risk reduction for stroke in patients with hypertension and left ventricular hypertrophy

Pharmacology

• Inhibition of vasoconstrictor and aldosterone-secreting effects
• Selective blocking of angiotensin II binding to AT1 receptor
• Thiazide diuretic effect on renal tubular electrolyte reabsorption

Dosage

• Usual starting dose of 50/12.5 is one tablet once daily
• Maximum dose is 100/25 once daily
• Antihypertensive effect attained within three weeks

Administration

• Can be administered with or without food
• May be administered with other antihypertensive agents

Interaction

• Potential interactions with potassium-sparing diuretics and potassium supplements
• Interaction with antidiabetic drugs
• Additive effect with other antihypertensive drugs
• Impaired absorption in the presence of anionic exchange resins

Contraindications

• Hypersensitivity to any component of the product
• Anuria
• Hypersensitivity to sulfonamide-derived drugs

Side Effects

• Symptomatic hypotension
• Hyperkalaemia
• Angioedema
• Vertigo
• Gastrointestinal disturbances
• Angina
• Palpitation
• Oedema
• Dyspnoea
• Headache
• Malaise
• Urticaria
• Pruritus
• Rash
• Hepatitis
• Atrial fibrillation
• Cerebrovascular accident
• Syncope
• Paraesthesia
• Hepatitis
• Anaphylaxis
• Cough
• Depression
• Erectile dysfunction
• Anaemia
• Thrombocytopenia
• Hyponatraemia
• Arthralgia
• Myalgia
• Renal impairment
• Rhabdomyolysis
• Tinnitus
• Photosensitivity
• Vasculitis

Pregnancy & Lactation

• Should be avoided in pregnancy unless essential
• Not recommended in breastfeeding
• Limited safety information during breastfeeding

Precautions & Warnings

• Hypersensitivity: Angiooedema
• Periodic determination of serum electrolytes
• Hypokalemia risk
• Impaired renal function risk
• Symptomatic hypotension risk

Use in Special Populations

• Usual regimens of therapy for patients with renal impairment with creatinine clearance >30 ml/min
• Loop diuretics preferred in severe renal impairment
• Not recommended for titration in patients with hepatic impairment
• Safety and effectiveness in pediatric patients not established

Overdose Effects

• Manifestations include hypotension, tachycardia, bradycardia, electrolyte depletion
• Supportive treatment for symptomatic hypotension

Therapeutic Class

• Combined antihypertensive preparations

Storage Conditions

• Do not store above 30°C
• Keep out of the reach of children

Related Brands

• Acusan Plus 50 mg+12.5 mg (Tablet) - concord-pharmaceuticals-ltd
• Angilock Plus 50 mg+12.5 mg (Tablet) - square-pharmaceuticals-plc
• Angilock Plus 100 mg+12.5 mg (Tablet) - square-pharmaceuticals-plc
• Angilock Plus 100 mg+25 mg (Tablet) - square-pharmaceuticals-plc
• Anin Plus 50 mg+12.5 mg (Tablet) - delta-pharma-ltd